CAPVAXIVE 4 ug/.5mL

CAPVAXIVE 4 ug/0.5mL is a pneumococcal 21-valent conjugate vaccine designed to help prevent pneumococcal disease. This intramuscular injection is suitable for individuals seeking protection against specific strains of pneumococcal bacteria.

CAPVAXIVE 4 ug/0.5mL is used to help prevent pneumococcal disease caused by the 21 serotypes included in the vaccine. This vaccine is typically administered to individuals who are at risk of pneumococcal infection, such as those with weakened immune systems or certain medical conditions. The primary use of this vaccine is to stimulate the body's immune response to help protect against these specific strains of pneumococcal bacteria.

Common effects of CAPVAXIVE 4 ug/0.5mL may include mild to moderate reactions at the injection site, such as redness, swelling, or pain. Some individuals may also experience general symptoms like fatigue, headache, or muscle aches. These effects are usually temporary and resolve on their own within a few days.

CAPVAXIVE 4 ug/0.5mL should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform the healthcare provider about any current illnesses or medications before receiving the vaccine.

CAPVAXIVE 4 ug/0.5mL may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving this vaccine. Alcohol consumption and certain immune-suppressing drugs may also affect the vaccine's effectiveness.